Skip to main content
Journal ArticleOPEN ACCESS

Increased serum microRNA-155 level associated with nonresponsiveness to hepatitis B vaccine

Clinical and Vaccine Immunology (2013) 20(7) 1089-1091
DOI: 10.1128/CVI.00044-13
14Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We compared the serum levels of microRNA-155 (miR-155) between subjects with normal response to hepatitis B vaccine and nonresponders. Results showed that serum expression of miR-155 was significantly higher in nonresponders than in responders (6.40 versus 2.55; Z = 2.125, P = 0.034), suggesting that overexpression of miR-155 is correlated with nonresponsiveness to hepatitis B vaccine. Copyright © 2013, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Xiong, Y., Chen, S., Liu, L., Zhao, Y., Lin, W., & Ni, J. (2013). Increased serum microRNA-155 level associated with nonresponsiveness to hepatitis B vaccine. Clinical and Vaccine Immunology, 20(7), 1089–1091. https://doi.org/10.1128/CVI.00044-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free